Markers of Favorable Response to Complement Inhibitors Therapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Markers of Favorable Response to Complement Inhibitors Therapy — Stella

Home/Myasthenia Gravis, Generalized/

View on ClinicalTrials.gov

Recruiting

Back to Myasthenia Gravis, Generalized trials

Trial locations(1 site)

Italy

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

Key details

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment target

~50 participants

Started

June 2024

Primary completion

June 2026

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.